Biocon Q4 net dips 54 pc at Rs 113 crore

Biotechnology major Biocon today reported a 54.51 per cent decline in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended March 31, 2014.

The company had posted a net profit of Rs 248.61 crore in the same period of the previous fiscal.

Net sales of the company rose to Rs 722.59 crore for the fourth quarter as against Rs 630.12 crore for the same period a year ago, Biocon Ltd said in a statement.

For the year ended March 31, 2014, the company's net profit declined by 18.69 per cent to Rs 413.72 crore from Rs 508.82 crore in the 2012-13 fiscal.

The company's net sales for the just-concluded fiscal rose to Rs 2,852.72 crore, as against Rs 2,427.60 crore in the previous year.

In a separate statement, the Bangalore-based firm said it has appointed Arun Chandavarkar as the Chief Executive Officer and Joint Managing Director.

The company's board also recommended a final dividend of Rs 5 per share (100 per cent) for the FY 2013-14.

Biocon shares were trading at Rs 481.10 apiece on the BSE, up 3.04 per cent from its previous close.


  • Listing of exchanges, shareholder right will boost market fundamentals

    Capital market regulator Securities and Exchanges Board of India (Sebi) announced a milestone change in the Indian capital market at its Monday board


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Sachin Shridhar

Pay well and ask no more

Well, the 7th pay co­mmission has done the obvious. One ...

Kuruvilla Pandikattu

Children, religion and altruism

It is assumed that religious families foster selflessness a­nd love ...

Dharmendra Khandal

For a lark, let's do something serious finally

It’s a sight to behold. As you drive through a ...


William D. Green

Chairman & CEO, Accenture